ArticleContact dermatitis2026
Occupational Contact Allergy to Components of Epoxy Resin Systems: Descriptive and Comparative Epidemiological Analyses Based on IVDK Data 2008-2022.
Article in Contact dermatitis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpoxy resin systems (ERS) frequently cause occupational allergic contact dermatitis.
objectivesTo analyze and update sensitization frequencies to epoxy resin, reactive diluents and hardeners in patients with occupational dermatitis (OD).
methodsRetrospective descriptive and comparative analysis of data collected by the Information Network of Departments of Dermatology (IVDK) from OD patients patch tested with bisphenol A diglycidyl ether (DGEBA) epoxy resin, 2008-2022.
resultsDGEBA sensitization declined overall, with fluctuations, from 4.2% in 2008-2010 to 2.9% in 2020-2022 (p = 0.0014). Adjusted odds ratios (ORs) were highest for plastics processors (11.7; 95% CI, 8.1-16.6), bricklayers, cement and concrete workers (6.4; 5.1-8.0), and painters/varnishers (5.3; 4.0-6.9). DGEBA-positive patients were most frequently co-sensitised to the reactive diluents 1,6-hexanediol diglycidyl ether (43.6%), 1,4-butanediol diglycidyl ether (35.7%), and phenyl glycidyl ether (30.8%), and to the hardener m-xylylenediamine (22.7%). DGEBA testing alone would not have identified 446 patients (1.9% of all DGEBA-tested OD patients) with sensitizations to reactive diluents or amine hardeners.
conclusionsIf contact allergy to ERS components is suspected, not only DGEBA, but also reactive diluents and hardeners should be patch tested. Prevention should prioritise exposure control, occupational hygiene, ongoing surveillance, and periodic test series updates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.